Plasma Aminothiol Compounds, but Not Serum Tumor Necrosis Factor Receptor II and Soluble Receptor for Advanced Glycation End Products, Are Related to the Cognitive Impairment in Alzheimer’s Disease and Mild Cognitive Impairment Patients-Reference-Cited by-同舟云学术

Plasma Aminothiol Compounds, but Not Serum Tumor Necrosis Factor Receptor II and Soluble Receptor for Advanced Glycation End Products, Are Related to the Cognitive Impairment in Alzheimer’s Disease and Mild Cognitive Impairment Patients

Published:2007 Issue:3-4 Volume:14 Page:163-167
ISSN:1021-7401
Container-title:Neuroimmunomodulation
language:en
Short-container-title:Neuroimmunomodulation

Author:

Hernanz Angel,De la Fuente Mónica,Navarro Mercedes,Frank Ana

Publisher

S. Karger AG

Subject

Endocrine and Autonomic Systems,Neurology,Endocrinology,Immunology

Reference20 articles.

1. Aβ as a bioflocculant: implications for the amyloid hypothesis of Alzheimer’s disease

2. Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated ‘acute phase response’ in the brain?

3. Increased cerebrospinal fluid Fas (Apo-1) levels in Alzheimer’s disease

4. Combination of serum markers related to several mechanisms in Alzheimer’s disease

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoying the enemy: soluble receptor for advanced glycation end products and cognitive impairment in neurodegenerative diseases—a systematic review and meta-analysis;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2024-08-08

2. Soluble receptor of advanced glycation end product as a biomarker in neurocognitive and neuropsychiatric disorders: A meta‐analysis of controlled studies;European Journal of Clinical Investigation;2024-05-03

3. Evaluation of Dietary Intake in Individuals with Mild Cognitive Impairment;Nutrients;2023-08-23

4. Quantitation of Brain and Blood Glutathione and Iron in Healthy Age Groups Using Biophysical and In Vivo MR Spectroscopy: Potential Clinical Application;ACS Chemical Neuroscience;2023-05-31

5. Altered central and blood glutathione in Alzheimer’s disease and mild cognitive impairment: a meta-analysis;Alzheimer's Research & Therapy;2022-02-05